These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35859025)

  • 1. A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor.
    Chrestia JF; Oliveira AS; Mulholland AJ; Gallagher T; Bermúdez I; Bouzat C
    Mol Neurobiol; 2022 Oct; 59(10):6076-6090. PubMed ID: 35859025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors.
    Oliveira ASF; Ibarra AA; Bermudez I; Casalino L; Gaieb Z; Shoemark DK; Gallagher T; Sessions RB; Amaro RE; Mulholland AJ
    Biophys J; 2021 Mar; 120(6):983-993. PubMed ID: 33609494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors.
    Oliveira ASF; Ibarra AA; Bermudez I; Casalino L; Gaieb Z; Shoemark DK; Gallagher T; Sessions RB; Amaro RE; Mulholland AJ
    bioRxiv; 2020 Sep; ():. PubMed ID: 32743575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 spike ectodomain targets α7 nicotinic acetylcholine receptors.
    O'Brien BCV; Weber L; Hueffer K; Weltzin MM
    J Biol Chem; 2023 May; 299(5):104707. PubMed ID: 37061001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline.
    Carlson EC; Macsai M; Bertrand S; Bertrand D; Nau J
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.
    Lagoumintzis G; Chasapis CT; Alexandris N; Kouretas D; Tzartos S; Eliopoulos E; Farsalinos K; Poulas K
    Food Chem Toxicol; 2021 Mar; 149():112009. PubMed ID: 33503469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence.
    Kalashnyk O; Lykhmus O; Izmailov M; Koval L; Komisarenko S; Skok M
    Biochem Biophys Res Commun; 2021 Jul; 561():14-18. PubMed ID: 34000512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.
    Farsalinos K; Eliopoulos E; Leonidas DD; Papadopoulos GE; Tzartos S; Poulas K
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonists or positive allosteric modulators of α7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
    Kalashnyk O; Lykhmus O; Sullivan R; Komisarenko S; Skok M
    Biochem Biophys Res Commun; 2024 May; 709():149825. PubMed ID: 38537599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice.
    Lykhmus O; Kalashnyk O; Koval L; Krynina O; Komisarenko S; Skok M
    Biochem Biophys Res Commun; 2022 Sep; 622():57-63. PubMed ID: 35843095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries.
    Lasala M; Corradi J; Bruzzone A; Esandi MDC; Bouzat C
    J Biol Chem; 2018 Jul; 293(27):10707-10717. PubMed ID: 29784875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
    Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
    J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of native α7 nicotinic ACh receptors and their contribution to depolarization-elicited exocytosis in human chromaffin cells.
    Pérez-Alvarez A; Hernández-Vivanco A; Alonso Y Gregorio S; Tabernero A; McIntosh JM; Albillos A
    Br J Pharmacol; 2012 Feb; 165(4):908-21. PubMed ID: 21790533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol as a modulator of α7 nicotinic receptors.
    Chrestia JF; Esandi MDC; Bouzat C
    Cell Mol Life Sci; 2022 Oct; 79(11):564. PubMed ID: 36282426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter GABA activates muscle but not α7 nicotinic receptors.
    Dionisio L; Bergé I; Bravo M; Esandi Mdel C; Bouzat C
    Mol Pharmacol; 2015; 87(3):391-400. PubMed ID: 25492812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant
    Stokes C; Garai S; Kulkarni AR; Cantwell LN; Noviello CM; Hibbs RE; Horenstein NA; Abboud KA; Thakur GA; Papke RL
    J Pharmacol Exp Ther; 2019 Aug; 370(2):252-268. PubMed ID: 31175218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental test of the nicotinic hypothesis of COVID-19.
    Godellas NE; Cymes GD; Grosman C
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2204242119. PubMed ID: 36279466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea interaction with α7 nicotinic acetylcholine receptor can underlie its therapeutic efficacy upon COVID-19.
    Lykhmus O; Kalashnyk O; Sullivan R; Skok M
    J Neuroimmunol; 2023 Dec; 385():578244. PubMed ID: 38016403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective.
    Andersen ND; Nielsen BE; Corradi J; Tolosa MF; Feuerbach D; Arias HR; Bouzat C
    Neuropharmacology; 2016 Aug; 107():189-200. PubMed ID: 26926428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.